Healthy Aging Health Center
This article is from the WebMD Feature Archive
For Your Health, Assert Yourself
March 26, 2001 -- After doctors diagnosed Richard Farrell with colon cancer in 1996, he underwent surgery and then chemotherapy. With the affected portion of his intestine removed, he thought he was on the road to recovery. But in 1999, more tumors were discovered. His surgeons said these were not operable and sent him back to his oncologist. She talked to Farrell about a regimen to make him comfortable but not cure him.
"'Palliative' is what she called it," recalls Farrell, a 67-year-old retiree who divides his time between Amsterdam, N.Y., where he worked 30 years as a senior food inspector for the state, and Florida, where he escapes the cold winters. The more his oncologist talked about making him comfortable, the more uncomfortable Farrell became. "I don't like the idea," he blurted out. Next thing he knew, he heard himself saying, "I want to go to Memorial Sloan Kettering."
His oncologist knew physicians at the renowned New York City cancer center and referred Farrell, who ended up in a clinical trial to test a new chemotherapy regimen, which for him turned out to be fairly successful. During his last exam, doctors told him they found no evidence of new tumors. But scans indicate there is a now a spot on his lung, and whether that represents something to worry about remains to be determined.
Through it all, Farrell, who is still on chemotherapy, says he tries to stay positive, buoyed by the support of his wife and four children. What does remain constant, however, is his take-charge attitude, which began the day he decided he didn't want to go home and just die.
Taking an active role in your healthcare is good for you, research suggests. The more actively involved you are in your healthcare, the better your results tend to be -- and the more satisfied you feel, according to the federal Agency for Healthcare Research and Quality (AHRQ). But developing an assertive attitude is not always second nature, especially for seniors who grew up in the "Doctors are God" era.
Fortunately, help is at hand. Growing numbers of patient advocacy organizations are springing up, ready to guide consumers through complaint processes or refer them to other sources of help. Agencies such as the AHRQ, a part of the U.S. Public Health Service, are producing guides on becoming an active patient. And patients like Richard Farrell are sharing their stories, inspiring others to emulate them.
Educate yourself
Before his diagnosis, Farrell says, "I knew absolutely nothing about colon cancer." And, he admits, at first he behaved a bit like a sheep. His doctor said he needed surgery, and so he checked in as soon as possible. During the recovery period between surgery and his first appointment with the oncologist to discuss chemotherapy, he had a lot of time to think. He swung into research mode. "I got on my computer and began to find out quite a bit," he says. "By the time I went to my oncologist, I was very well informed."
It's important to note that not all information on the Internet is accurate -- and just because a treatment is available, it may not be right for you. But besides making efforts to educate yourself, Farrell says, it's important to let your doctor know you're doing it -- and that you don't want to be an uninformed, passive patient.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


